Treatment of fibromyalgia and chronic fatigue syndrome

Details for Australian Patent Application No. 2001255223 (hide)

Owner Pharmacia and Upjohn Company LLC

Inventors Marshall, Robert C.; McCall, Robert B; Robertson, David W

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001255223

PCT Pub. Number WO01/87308

Priority 60198960 21.04.00 US

Filing date 17 April 2001

Wipo publication date 26 November 2001

Acceptance publication date 21 October 2004

International Classifications

A61K 031/505 - Pyrimidines

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61K 031/40 - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

A61K 031/47 - Quinolines

A61K 031/48 - Ergoline derivatives, e.g. lysergic acid, ergotamine

Event Publications

21 October 2004 Application Accepted

  Published as AU-B-2001255223

17 February 2005 Standard Patent Sealed

14 December 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001255224

2001255222